Alzheimer's disease in Down syndrome: Neurobiology and risk
- 1 January 2007
- journal article
- review article
- Published by Wiley in Mental Retardation and Developmental Disabilities Research Reviews
- Vol. 13 (3), 237-246
- https://doi.org/10.1002/mrdd.20163
Abstract
Down syndrome (DS) is characterized by increased mortality rates, both during early and later stages of life, and age‐specific mortality risk remains higher in adults with DS compared with the overall population of people with mental retardation and with typically developing populations. Causes of increased mortality rates early in life are primarily due to the increased incidence of congenital heart disease and leukemia, while causes of higher mortality rates later in life may be due to a number of factors, two of which are an increased risk for Alzheimer's disease (AD) and an apparent tendency toward premature aging. In this article, we describe the increase in lifespan for people with DS that has occurred over the past 100 years, as well as advances in the understanding of the occurrence of AD in adults with DS. Aspects of the neurobiology of AD, including the role of amyloid, oxidative stress, Cu/ZN dismutase (SOD‐1), as well as advances in neuroimaging are presented. The function of risk factors in the observed heterogeneity in the expression of AD dementia in adults with DS, as well as the need for sensitive and specific biomarkers of the clinical and pathological progressing of AD in adults with DS is considered. © 2007 Wiley‐Liss, Inc. MRDD Research Reviews 2007;13:237–246.Keywords
This publication has 151 references indexed in Scilit:
- Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brainNeurobiology of Aging, 2007
- Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down SyndromeArchives of Neurology, 2007
- Cholesterol level, statin use and Alzheimer's disease in adults with Down syndromeNeuroscience Letters, 2007
- Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementiaNeurobiology of Aging, 2006
- Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun StudyNeurobiology of Aging, 2005
- Elevated sex-hormone binding globulin in elderly women with Alzheimer’s diseaseNeurobiology of Aging, 2004
- Gene dose effect of the APOE-ϵ4 allele on plasma HDL cholesterol level in patients with Alzheimer’s diseaseNeurobiology of Aging, 2002
- Oxidative damage in Alzheimer'sNature, 1996
- Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroNature, 1995
- Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's diseaseNeuroscience Letters, 1988